Abdallah Geara, MD

Lafayette R, Barbour SJ, Brenner RM, Campbell KN, Doan T, Eren N, Floege J, Jha V, Kim BS, Liew A, Maes B, Pal A, Pecoits-Filho R, Phoon RKS, Rizk DV, Suzuki H, Tesař V, Trimarchi H, Wei X, Zhang H, Barratt J; ORIGIN Phase 3 Trial Investigators. A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy , NEJM: 2026

Curto A, Martinez Leon VJ, Geara AS. Daratumumab for Treatment of Refractory Podocytopathy: A Case Report , Kidney Medicine: 2026

Geara AS, Chen KB, Simmons W. Patient and Provider Perspectives on the Patient Journey in Immunoglobulin A Nephropathy , Kidney Medicine: 2026

Gerber JM, Dehdashtian E, Hu G, Gregoire C, Borie D, Bindal P, Cerny J, Geara A, Schett G, Caricchio R. "Successful autologous CD19 CAR T cell therapy following severe lupus flare during immunosuppressive washout in refractory lupus nephritis" , Lupus Sci Med.: 2025

Ella Eisinger, Abdallah S Geara, Bryan Chang, Preethi Reddivari, Julia Ford, Ora Gewurz-Singer, Duvuru Geetha "Avacopan for ANCA-associated vasculitis: Beyond the 52-week treatment course" , Clinical Nephrology: 2025

Gupta S, Kaunfer SA, Chen KL, Dias JA, Vijayan A, Rajasekaran A, Prosek J, Truong HL, Wood A, Bassil C, Renaghan AD, Shah CV, Zhang J, Glezerman I, Carlos C, Kelly K, Passero CJ, Drappatz J, Abudayyeh A, Shin D, Sperati CJ, Yelvington BJ, Kanduri SR, Neyra JA, Edmonston D, Shirali AC, Bansal A, Geara A, Mithani Z, Ziolkowski SL, Rashidi A, Jakubowski J, Pujari A, Bond DA, Dotson EK, Wall SA, Patton JT, Barreto JN, Hermann SM, Sheikh MS, Baz RC, Lee JH, Lucchesi N, Kolman M, Rasheed MA, Afzal A, Kang D, Mahesh A, Hsu R, Nicolaysen A, Tefera K, Schretlen C, Miller RM, Velez JCQ, Flannery AH, Aklilu AM, Anand S, Chandrasekhara S, Donley V, Patel A, Ni J, Krishnamurthy S, Ali R, Yilmam OA, Wells SL, Ortega JL, Green-Lingren OL, Leaf RK, Sise ME, Nayak L, LaCasce AS, Leung N, Leaf DE. "Glucarpidase for Treatment of High-Dose Methotrexate Toxicity" , Blood: 2025

Keith W Hamilton 1, Elvis Hua 2, Lauren Dutcher 1, Holly Fernandez Lynch 3, Paul Junker 4, Abigail G Doucette 5, Danielle Werner 6, Ethan Z Kannel 7, Thomas Civitello 7, Peter Gabriel 5, Vivek N Ahya 6 8, Dina A Jacobs 9, Alfred Garfall 10, Keith Pratz 10, Kathleen O Degnan 1, Emily A Blumberg 1, Donna Capozzi 11, Ethan Craig 12 13, Patricia Takach 14, Aimee S Payne 15, Abdallah Geara 16, Helen Koenig 1, Lawrence Holzman 16, Pablo Tebas 1 Implementation of an Approach to Equitable Allocation of SARS-CoV-2 Monoclonal Antibodies for Preexposure Prophylaxis: Experience From a Single Medical Center , Open Forum Infectious Disease: 2024

Reza Zonozi, MD, Faten Aqeel, MD, Dustin Le, MD, Frank B. Cortazar, MD, Jugal, Thaker, MD, Maria Jose Zabala Ramirez, MD, Sebastian Eduardo Sattui Cortes, MD, Rose Mary Attieh, MD, Madeline Chung, MD, David H. Bulbin, DO, Aisha Shaikh, MD, Karina Guaman, BA, Julia Ford, MD, Colin Diffie, MD, Ora Gewurz-Singer, MD, Gabriel Sauvage, BS, Anushya Jeyabalan, MD, Abdallah Geara, MD, Isabelle Ayoub, MD, Andrew Bomback, MD, Lara L. Khoury, MD, Jason C. George, DO, Kenar D., Jhaveri, MD, Vimal Kumar Derebail, MD, John L. Niles, MD, Duvuru Geetha, MD "Real-world experience with avacopan in ANCA-associated vasculitis" , Kidney International Reports: 2024

Michelle N Rheault 1, Charles E Alpers 1, Jonathan Barratt 1, Stewart Bieler 1, Pietro Canetta 1, Dong-Wan Chae 1, Gaia Coppock 1, Ulysses Diva 1, Loreto Gesualdo 1, Hiddo J L Heerspink 1, Jula K Inrig 1, Gianna M Kirsztajn 1, Donald Kohan 1, Radko Komers 1, Laura A Kooienga 1, Kenneth Lieberman 1, Alex Mercer 1, Irene L Noronha 1, Vlado Perkovic 1, Jai Radhakrishnan 1, William Rote 1, Brad Rovin 1, Vladimir Tesar 1, Hernán Trimarchi 1, James Tumlin 1, Muh Geot Wong 1, Howard Trachtman 1; DUPRO Steering Committee and DUPLEX Investigators "Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis" , NEJM: 2023

Rovin, B, et al "Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial" , Lancet: 2023